New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 29, 2014
18:40 EDTLGF, BNNY, RTRX, VEEV, EXPR, BLOX, NMBL, OVTI, GLUU, SPLK, CRM, AVGOOn The Fly: After Hours Movers
UP AFTER EARNINGS: OmniVision (OVTI), up 17.9% after reporting better than expected fourth quarter results and first quarter guidance above expectations... Veeva Systems (VEEV), up 6.2%... Avago (AVGO), up 1.5% after reporting quarterly results... Nimble Storage (NMBL), up 3.76%... ALSO HIGHER: Retrophin (RTRX), up 29.27% following license agreement with Mission Pharmacal for Thiola and revised guidance... salesforce.com (CRM), up 1.75% after announcing global strategic partnership with Microsoft (MSFT). DOWN AFTER EARNINGS: Infoblox (BLOX), down 28.12% after guiding below analyst estimates for fourth quarter and announcing that CEO Robert Thomas is stepping down... Annies (BNNY), down 16.86%... Splunk (SPLK), down 9.15%... Express (EXPR), down 10.27% after reporting quarterly results and announcing that it will close 50 stores over the next 36 months... Lions Gate (LGF), down 5.99%. ALSO LOWER: Glu Mobile (GLUU), down 7.4%.
News For OVTI;VEEV;AVGO;NMBL;RTRX;CRM;BLOX;BNNY;SPLK;EXPR;LGF;GLUU From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
November 18, 2014
07:56 EDTCRMSalesforce.com remains a top large cap growth pick at BofA/Merrill
BofA/Merrill reiterates Salesforce.com as a top large cap growth pick for 2014 based on potential for accelerating operating income and TAM of $100B. Shares are Buy rated with a $73 price target.
November 17, 2014
08:48 EDTAVGOSkyworks, Avago, and RF Micro Devices recommended at BofA/Merrill
Subscribe for More Information
08:06 EDTRTRXRetrophin names Laura Clague as CFO
Subscribe for More Information
November 14, 2014
16:26 EDTCRMNasdaq clear leader as major averages end week higher
Subscribe for More Information
13:38 EDTSPLKSplunk November volatility elevated into Q3 and outlook
Subscribe for More Information
November 13, 2014
18:40 EDTRTRXOn The Fly: After Hours Movers
UP AFTER EARNINGS: TubeMogul (TUBE), up 12.4%... Weibo (WB), up 3.2%... Nordstrom (JWN), up 3.1%. ALSO HIGHER: Geron (GERN), up 30.7% after announcing a global strategic collaboration with Janssen Biotech... Baker Hughes (BHI), up 16.2% following reports that the company is in talks to be acquired by Halliburton (HAL)... Halliburton is up 1.4%... Pandora (P), up 4% after announcing a conference call to discuss Web IV proceeding... AmerisourceBergen (ABC), up 1.1% after being awarded a $4.06B government contract. DOWN AFTER EARNINGS: Retrophin (RTRX), down 6.6%... Phoenix New Media (FENG), down 8.4%... Voxeljet AG (VJET), down 8.6%... Intrexon (XON), down 1.1%... Youku Tudou (YOKU), down 5.7%... Applied Materials (AMAT), down 2.5%. ALSO LOWER: Puma Biotechnology (PBYI), down 6.9% following PB272 Phase II Trial results... EnLink Midstream (ENLK), down 4.8% after filing to sell 10.5M common units representing limited partners.
17:19 EDTRTRXRetrophin lowers FY14 revenue view to $26M-$29M from $30M-$35M
Based on the slower than expected progress while initially bringing patients back on Thiola after the supply outage, Retrophin is revising its 2014 financial guidance. The company now expects full-year 2014 revenues to be between $26M and $29M, down from the previously listed range of $30M to $35M. The company is removing the previously stated 2015 financial guidance and will be providing new 2015 financial guidance when year-end financial results are reported, which will be its new standard of practice.
17:16 EDTRTRXRetrophin reports Q3 EPS (53c) vs (20c) last year
Net sales for the third quarter of 2014 were $8.3M from product sales of Chenodal, Thiola and Vecamyl. Retrophin reported no revenue for the third quarter of 2013.
12:03 EDTCRMBlackBerry announces agreement with Salesforce.com
Subscribe for More Information
10:47 EDTLGFLionsgate and CBS Films announce multi-year film distribution partnership
Subscribe for More Information
08:24 EDTCRMSalesforce.com November volatility elevated into Q3 and outlook
Salesforce.com November call option implied volatility is at 50, December is at 38, January is at 33; compared to its 26-week average of 34 according to Track Data, suggesting large near term price movement into the expected release of Q3 results on November 19.
November 12, 2014
17:02 EDTCRMSalesforce.com signs agreement to purchase 50 Fremont Street building
Subscribe for More Information
November 11, 2014
10:00 EDTSPLKOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:22 EDTSPLKSplunk initiated with a Neutral at Macquarie
Subscribe for More Information
07:13 EDTSPLKSplunk initiated with a Neutral at Macquarie
November 10, 2014
16:39 EDTRTRXRetrophin names Stephen Aselage as CEO
Subscribe for More Information
15:44 EDTSPLKAmazon Web Services to hold a conference
Subscribe for More Information
10:14 EDTLGFHigh option volume stocks
High option volume stocks: UN PAGP PHH RGLS DF URA CERS DNDN LGF CALL
07:54 EDTCRMChecks on Salesforce.com positive, says Oppenheimer
Subscribe for More Information
07:35 EDTSPLKSplunk volatility increases into Q3 and outlook
Splunk November call option implied volatility is at 92, December is at 65, January is at 57; compared to it 26-week average of 56 according to Track Data, suggesting large price movement into the expected release of Q3 on November 20.
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use